-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gxqzlcye5r8QSVne6T6XDLCJWOxxeRba2xoC11bEwlfrI/S68RJrWcJP0801Hxkv l5p0o8ca0UhwecoWXl0wyQ== 0000891618-99-000279.txt : 19990202 0000891618-99-000279.hdr.sgml : 19990202 ACCESSION NUMBER: 0000891618-99-000279 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENELABS TECHNOLOGIES INC /CA CENTRAL INDEX KEY: 0000874443 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943010150 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: SEC FILE NUMBER: 033-97336 FILM NUMBER: 99517490 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 6503969500 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 POS AM 1 FORM S-3, POST-EFFECTIVE AMENDMENT #1 1 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 29, 1999 REGISTRATION NO. 33-97336 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------ POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ------------------------------ GENELABS TECHNOLOGIES, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) ------------------------------ CALIFORNIA 94-3010150 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
505 PENOBSCOT DRIVE REDWOOD CITY, CALIFORNIA 94063-4738 (650) 369-9500 (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES) ------------------------------ MATTHEW M. LOAR VICE PRESIDENT, FINANCE 505 PENOBSCOT DRIVE REDWOOD CITY, CALIFORNIA 94063-4738 (650) 369-9500 (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF AGENT FOR SERVICE) ------------------------------ WITH A COPY TO: GREGORY C. SMITH, ESQ. SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP 525 UNIVERSITY AVENUE, SUITE 220 PALO ALTO, CALIFORNIA 94301 (650) 470-4500 ------------------------------ Approximate date of commencement of proposed sale to public: Not applicable If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [ ] If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. [ ] If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ] If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [ ] 2 ------------------------------ EXPLANATORY NOTE Pursuant to a Registration Statement on Form S-3 (File No. 33-97336) (the "Registration Statement"), the Registrant registered an aggregate of 9,750,000 shares of Common Stock, no par value (the "Common Stock"), of the Registrant. The Registration Statement was declared effective on October 2, 1995. Under the terms of Unit Purchase Agreements dated August 18 and 23, 1995 among the Registrant and certain holders of the shares offered under the Registration Statement, the Registrant was required to keep the Registration Statement effective until four years after the Closing Date under such Unit Purchase Agreements or such earlier date as all of the securities registered pursuant to the Registration Statement have been sold or may be sold under Rule 144 of the Securities Action of 1933, as amended (the "Securities Act"). Accordingly, this Post-Effective Amendment No. 1 to the Registration Statement is being filed for the purpose of deregistering 7,216,825 shares of the Common Stock, which the Company believes are now eligible for resale pursuant to Rule 144(k) of the Securities Act. ------------------------------ 2 3 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Redwood City, State of California, on January 29, 1999. GENELABS TECHNOLOGIES, INC. By: /s/ Irene A. Chow, Ph.D. ------------------------------------- Irene A. Chow, Ph.D. President and Chief Executive Officer Pursuant to the requirements of the Securities Act , this Post-Effective Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities indicated on January 22, 1999.
SIGNATURE TITLE - ------------------------------ ------------------------------- /s/ Irene A. Chow, Ph.D. President and Chief Executive - ------------------------------ Officer and Director Irene A. Chow, Ph.D. (Principal Executive Officer) /s/ James A.D. Smith Chief Operating Officer - ------------------------------ (Principal Financial Officer) James A.D. Smith /s/ Matthew M. Loar Director, Finance and Controller - ------------------------------ (Principal Accounting Officer) Matthew M. Loar /s/ J. Richard Crout, M.D. Director - ------------------------------ J. Richard Crout, M.D. /s/ Thomas E. Dewey, Jr. Director - ------------------------------ Thomas E. Dewey, Jr. Director - ------------------------------ Frank L. Douglas, M.D., Ph.D. /s/ Edgar G. Engleman, M.D. Director - ------------------------------ Edgar G. Engleman, M.D. /s/ Arthur Gray, Jr. Director - ------------------------------ Arthur Gray, Jr. /s/ H.H. Haight Director - ------------------------------ H.H. Haight /s/ Alan Y. Kwan Director - ------------------------------ Alan Y. Kwan - ------------------------------ Director Nina K. Wang
3 -----END PRIVACY-ENHANCED MESSAGE-----